Apogee Therapeutics宣布,将在即将举行的2025年欧洲皮肤病与性病学会大会上发表其药物Apg777治疗中重度特应性皮炎的2期Apex试验16周数据的突破性报告。
Apogee Therapeutics宣布,将在即将举行的2025年欧洲皮肤病与性病学会大会上发表其药物Apg777治疗中重度特应性皮炎的2期Apex试验16周数据的突破性报告。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.